STRUCTURAL-ANALYSIS OF HLA-B40 EPITOPES

被引:23
|
作者
KAWAGUCHI, G
KATO, N
KASHIWASE, K
KARAKI, S
KOHSAKA, T
AKAZA, T
KANO, K
TAKIGUCHI, M
机构
[1] UNIV TOKYO,INST MED SCI,DEPT TUMOR BIOL & IMMUNOL,4-6-1 SHIROKANEDAI,MINATO KU,TOKYO 108,JAPAN
[2] JAPANESE RED CROSS CENT BLOOD CTR,TOKYO,JAPAN
[3] NATL CHILDRENS MED CTR,DEPT IMMUNOL,TOKYO,JAPAN
[4] OLYMPUS OPT CO LTD,BIOMED RES CTR,TOKYO,JAPAN
关键词
D O I
10.1016/0198-8859(93)90125-K
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Two genes encoding HLA-B60 or HLA-B61 were cloned from Japanese and the exons of their genes were sequenced. One silent mutation was observed at the exon 1 between HLA-B60 (B*40012) and B*40011. Seven nucleotide substitutions were seen at the exon 3 between HLA-B61 (B*4006) and B*4002. Three substitutions at codon 95, CTC in B*4002 to TGG in B*4006, changed Leu in B*4002 to Trp in B*4006, while two substitutions at codon 97, AGC in B*4002 and ACG in B*4006, changed Ser in B*4002 to Thr in B*4006. Since B*4002 shares the epitope of alloantibodies specific for HLA-B61, two HLA-B61 subtypes are discriminated by two amino acid substitutions at residues 95 and 97. B*40012 and B*4006 differ by four amino acid substitutions on the beta sheet and five amino acid substitutions on the alpha2 helix. Since the residues at the beta sheet seem hardly to affect the binding of alloantibody, it is suspected that the residues on the alpha2 helix provide epitopes for alloantibodies that discriminate allospecificity between HLA-B60 and HLA-B61.
引用
收藏
页码:193 / 198
页数:6
相关论文
共 50 条
  • [1] HEMANGIOMA AND HLA-B40 ANTIGEN
    MAJSKY, A
    ABRAHAMOVA, J
    BEK, V
    [J]. TISSUE ANTIGENS, 1980, 15 (02): : 220 - 221
  • [2] INCREASED FREQUENCY OF HLA-B40 IN PATIENTS WITH PARACOCCIDIOIDOMYCOSIS
    LACERDA, GB
    ARCEGOMEZ, B
    TELLES, FQ
    [J]. JOURNAL OF MEDICAL AND VETERINARY MYCOLOGY, 1988, 26 (04): : 253 - 256
  • [3] LINK BETWEEN HLA-B40 AND DIALYSIS ENCEPHALOPATHY
    GARRETT, P
    SPENCER, S
    MULCAHY, D
    HANLY, P
    HANSON, JS
    DONOHOE, JF
    CARMODY, M
    ODWYER, WF
    [J]. KIDNEY INTERNATIONAL, 1985, 28 (02) : 333 - 333
  • [4] EVIDENCE FOR 2 NEW SPLITS OF HLA-B40
    KENNEDY, LJ
    MADRIGAL, JA
    MARSH, SGE
    BODMER, JG
    [J]. IMMUNOGENETICS, 1989, 30 (06) : 515 - 519
  • [5] Significance of HLA-B40 alleles in Japanese patients with aplastic anemia
    Nakamura, A
    Shichishima, T
    Andoh, S
    Terasawa, T
    Maruyama, Y
    [J]. BLOOD, 2003, 102 (11) : 514A - 514A
  • [6] Detection of the HLA-B40:01:35 allele in a Taiwanese individual
    Yang, Kuo-Liang
    Lin, Py-Yu
    [J]. HLA, 2024, 103 (03)
  • [7] INCREASED INCIDENCE OF HLA-B40 IN HEMOLYTIC UREMIC SYNDROME (HUS)
    SHETH, KJ
    HUNTER, JB
    LEICHTER, HE
    GILL, JC
    [J]. KIDNEY INTERNATIONAL, 1989, 35 (01) : 231 - 231
  • [8] THE ASSOCIATION BETWEEN LICHEN SCLEROSUS ET ATROPHICUS AND HLA-B40
    HARRINGTON, CI
    GELSTHORPE, K
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 1981, 104 (05) : 561 - 562
  • [9] ASSOCIATION BETWEEN HLA-B40 AND ALCOHOLIC LIVER-DISEASE WITH CIRRHOSIS
    BELL, H
    NORDHAGEN, R
    [J]. ACTA MEDICA SCANDINAVICA, 1978, : 13 - 13
  • [10] Identification of a new allele polymorphism (HLA-B*40:79) and correlation with the HLA-B40 (B60 and B61) antigens
    Tilanus, M. G. J.
    van Dijk, A.
    van de Velde, H.
    Hepkema, Bouke
    [J]. TISSUE ANTIGENS, 2013, 82 (04): : 293 - 294